AGIR à Dom Clinical Trials
Sponsors / AGIR à Dom
According to ClinicalTrials.gov, AGIR à Dom has served as lead sponsor on 35 registered trials. Across the portfolio, 3 are in recruitment, 1 are active non-recruiting, and 18 have reached completion. 4 trials have been terminated or withdrawn. The most common reasons cited for termination include safety concerns, slow or insufficient recruitment. Across the portfolio, planned enrollment totals 5,374 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.
35
Total Trials
3
Recruiting
1
Other Active
18
Completed
4
Terminated / Withdrawn
5,374
Total Enrollment
Termination reasons: Other50% · Safety25% · Recruitment25%
Recent Terminations
- ALS"The study was terminated early due to insufficient recruitment despite mitigation measures, as enrolment rates could not meet protocol objectives. Academic thesis scheduling constraints also contributed. No safety concerns were identified."
- Chronic Obstructive Pulmonary Disease"pilot feasibility study completed"
- Chronic Obstructive Pulmonary Disease"Recruiting difficulties"
- NCT01573897 Stopped Nov 2016Diabetic Foot"Difficulty including subjects corresponding to the criteria."
Active Trials (1 total)
- NCT05653804
- NCT02057783
- NCT05197855
- NCT05803707